Six Months of Parathyroid Hormone (1–84) Administered Concurrently Versus Sequentially with Monthly Ibandronate Over Two Years: The PTH and Ibandronate Combination Study (PICS) Randomized Trial

CONTEXT: PTH therapy improves bone mineral density (BMD) and decreases fractures in postmenopausal osteoporosis, but cost and the burden of daily injections limit its use. OBJECTIVE: We evaluated two novel approaches to the use of 6 months of PTH therapy over 2 yr. DESIGN, SETTING, PARTICIPANTS, AND...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Schafer, Anne L., Sellmeyer, Deborah E., Palermo, Lisa, Hietpas, Jean, Eastell, Richard, Shoback, Dolores M., Black, Dennis M.
Format: Artigo
Idioma:Inglês
Publicat: Endocrine Society 2012
Matèries:
Endocrine Care
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3674294/
https://ncbi.nlm.nih.gov/pubmed/22791766
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jc.2012-1844
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars